Geom Therapeutics, Inc. — Form D
Geom Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-04-11. The offering totals $4.5M, of which $4.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-04-11
- Form: D
- Accession: 0001243233-17-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.5M
- Amount sold: $4.4M
- Remaining: $145K
- Investors: 17
- Date of first sale: 2017-03-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-284519
Issuer
- Name: Geom Therapeutics, Inc.
- CIK: 0001702693
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 826A Vallejo Street, SAN FRANCISCO, CA, 94133
- Phone: 415-533-3236
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| COOPER COLLINS | Director | SAN ANTONIO, TX |
| Dov Goldstein | Director | Houston, TX |
| Yong-Zu Kim | Director | San Francisco, CA |
| Sejin Park | Director | San Francisco, CA |
| Dirk Thye | Director | South San Francisco, CA |
| Dirk Thye | Executive Officer | South San Francisco, CA |
More